Optimizing Value Regulatory and Market Access Considerations

Event-Datum: 03.12.2019

NDA would like to invite you to join us for a morning seminar where our presenters will share their experiences and provide their insights and considerations in order to optimize the value of your development program.

Date: Tuesday 3rd of December 2019
Time: 09:00- 12:15 (opportunity to book 1-1 meetings from 13:15)
Venue: Bio-Technopark Schlieren-Zürich, Wagistrasse 25, 8952 Schlieren
Registration: zurich@ndareg.com, RSVP by Friday 29th November 2019 

09:00 Welcome – Claes Buxfeldt, Director NDA HTA Advisory Board and Stephanie Krumholz, General Manager NDA Switzerland
09:15 Session 1: Challenges in drug development – Professor Steffen Thirstrup
10:15 Coffee break
10:35 Session 2: HTA and Europe – where are we heading? – Professor Mira Pavlovich – Ganascia
12:05 Concluding remarks and take home messages
13:15 – 15:30 Ask the Experts – To book a 20 min slot to speak directly with our experts send an email to anna.perrin@ndareg.com